10% Off
10% Off
marketed by DR.REDDY`S LAB LTD (AQURA_MS)
• 15TAB
₹297.00
M.R.P.: ₹330
10% Off
Inclusive of all taxes
CC 74 is a combination of two medications are coral calcium and vitamin d3. it is used to strengthen the bones and prevent bone breakage. by using this medication, it provides an adequate supply of calcium to the bones. this medication's most common side effects are nausea, vomiting, loss of appetite, headache, increased thirst, increased urination, weakness, tiredness, and irregular heartbeat
hypersensitivity kidney problem lung problem malabsorption syndrome.
babies: not applicable.
lactating mother: safe if prescribed, studies have shown evidence that this medication crosses the placenta and appears in breast milk.
pregnancy: safe if prescribed, studies have shown limited evidence of side effects.
alcohol: avoid alcohol consumption while on this medication it may cause severe liver damage.
driving: consult your doctor.
studies have shown unlikely to affect your ability to drive.
kidney: this medication should be used with caution in patients with kidney disease.
liver: this medication is not recommended in patients with severe liver disease.
consult your doctor dose adjustment is needed based on the severity of the disease.
.
Nausea Vomiting Loss of appetite Constipation Stomach upset.
CC 74 works by increasing the plasma calcium levels, leading to decreased calcium flux in the blood, thereby increasing calcium deposition into bone..
If you miss a dose, take it as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
•CC 74 needs to be taken once a week and you should take it on the same day of next week.
• avoid alcohol consumption while taking this medication as it may lead to liver damage.
• do not stop taking this medication unless told by your doctor.
• inform your doctor if you have diabetes, so sugar-free calcium supplements will be given.
• advise the patient to limit intake of oxalate-rich foods such as soy, green leafy vegetables and animal protein to avoid reduced absorption calcium oxalate formation..
• coral calcium + abciximab: concurrent use leads to increase in abciximab levels by decreasing coral calcium. • coral calcium + alteplase: concurrent use leads to increase in alteplase levels by decreasing coral calcium. • coral calcium + oxprenolol: concurrent use leads to increase in oxprenolol levels by decreasing coral calcium. • coral calcium + tenecteplase: concurrent use leads to increase in tenecteplase levels by decreasing coral calcium. .
100% Authentic
Easy Return